Achillion Pharmaceuticals (ACHN)
Achillion Pharmaceuticals Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 64.58M | 53.57M | 65.14M | 99.58M | 46.41M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | 0.017M | 0.103M | 0.093M | 0.363M | 0.093M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Inventory | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Prepaid Expenses | 2.38M | 1.423M | 2.033M | 1.907M | 2.741M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 66.97M | 55.09M | 67.26M | 101.85M | 49.25M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accumulated Depreciation | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Property, Plant & Equipment | 1.371M | 0.994M | 1.06M | 0.825M | 0.406M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | 5.453M | 26.38M | 24.86M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Goodwill & Intangibles | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Assets | 0.152M | 0.152M | 0.152M | 0.152M | 0.152M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 6.989M | 27.54M | 26.09M | 0.987M | 0.696M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 73.96M | 82.63M | 93.36M | 102.83M | 49.94M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | 0.333M | 0.141M | 0.139M | 0.137M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Accounts Payable | 4.896M | 4.795M | 4.175M | 4.168M | 3.895M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | 4.169M | 4.008M | 4.092M | 3.735M | 2.46M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Revenues | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 9.398M | 8.944M | 8.406M | 8.04M | 6.355M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | 0.611M | 0.229M | 0.265M | 0.301M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Long Term Liabilities | 0.611M | 2.718M | 2.754M | 2.79M | 2.489M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 10.01M | 11.66M | 11.16M | 10.83M | 8.844M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 70.64M | 69.79M | 69.74M | 69.72M | 58.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | 0.071M | 0.07M | 0.07M | 0.07M | 0.058M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Additional Paid-in Capital | 348.60M | 346.52M | 345.38M | 344.71M | 282.57M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Retained Earnings | -284.74M | -275.60M | -263.22M | -252.78M | -241.53M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Shareholder's Equity | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 63.95M | 70.97M | 82.20M | 92.00M | 41.10M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 73.96M | 82.63M | 93.36M | 102.83M | 49.94M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |